Researchers propose a strategy to stratify risk of progression from mild cognitive impairment to Alzheimer’s

The projected cost of caring for millions of individuals who have Alzheimer’s disease (AD) worldwide will exceed a $1 trillion in a few years. In addition to the enormous health burden, patients and their caregivers experience financial, physical and psychological strain. A theory regarding repeated drug failure in AD is that patients undergoing experimental therapies are selected too late in the disease process. Therefore, it is important to identify patients at a high risk of progression to AD in early stages of the disease.

Nzovu warns truant mining firms

By BUUMBA CHIMBULU

GREEN Economy and Environment Minister, Collins Nzovu, has sounded a warning that Government will not hesitate to shut down mining companies not following the set regulations, especially repeated offenders.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.


Long-term collection of patient-reported outcome data in oncology trials: Important and feasible

Patient-reported outcome (PRO) data are collected in oncology trials to determine patients’ perspectives of cancer treatment—unfortunately often too briefly, for example only up to the point when an X-ray shows tumor growth and treatment is discontinued. As a result, it is not possible, for example, to reliably assess the impact on patients’ lives of disease progression seen on X-rays or the long-term side effects of cancer treatment.

WB commends UPND Govt

By ANDREW MUKOMA

THE World Bank has commended the United Party for National Development government (UPND) for providing a conducive business environment for the private sector to flourish.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.